The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
6-chloro-3-(1-(3,4-dichlorophenyl)-4,5-diphenyl-1H-imidazol-2-yl)-7-methyl-4H-chromen-4-one ID: ALA4869150
PubChem CID: 164624644
Max Phase: Preclinical
Molecular Formula: C31H19Cl3N2O2
Molecular Weight: 557.86
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cc2occ(-c3nc(-c4ccccc4)c(-c4ccccc4)n3-c3ccc(Cl)c(Cl)c3)c(=O)c2cc1Cl
Standard InChI: InChI=1S/C31H19Cl3N2O2/c1-18-14-27-22(16-25(18)33)30(37)23(17-38-27)31-35-28(19-8-4-2-5-9-19)29(20-10-6-3-7-11-20)36(31)21-12-13-24(32)26(34)15-21/h2-17H,1H3
Standard InChI Key: XNUWMPOQRIYTDT-UHFFFAOYSA-N
Molfile:
RDKit 2D
38 43 0 0 0 0 0 0 0 0999 V2000
2.4832 -3.8796 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4820 -4.6991 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1901 -5.1081 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1883 -3.4707 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8969 -3.8760 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8957 -4.6966 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6019 -5.1056 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3138 -4.6986 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3150 -3.8780 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6043 -3.4644 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.0242 -5.1056 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1074 -5.9185 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.9062 -6.0906 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3168 -5.3840 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7716 -4.7753 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.1285 -5.2999 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6066 -5.9640 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4188 -5.8812 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7540 -5.1350 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2708 -4.4707 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4603 -4.5568 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2362 -6.8336 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7523 -7.4935 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0820 -8.2404 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8953 -8.3286 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3778 -7.6639 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0455 -6.9196 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5977 -5.9226 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.7754 -3.4711 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7740 -5.1071 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
6.9428 -3.9800 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7222 -3.7305 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8944 -2.9325 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2883 -2.3831 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5072 -2.6373 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3386 -3.4348 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6724 -2.6825 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
7.4593 -1.5840 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
5 10 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 10 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 11 1 0
8 11 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
14 16 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 22 1 0
13 22 1 0
7 28 2 0
1 29 1 0
2 30 1 0
31 32 2 0
32 33 1 0
33 34 2 0
34 35 1 0
35 36 2 0
36 31 1 0
15 31 1 0
33 37 1 0
34 38 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 557.86Molecular Weight (Monoisotopic): 556.0512AlogP: 9.25#Rotatable Bonds: 4Polar Surface Area: 48.03Molecular Species: NEUTRALHBA: 4HBD: ┄#RO5 Violations: 2HBA (Lipinski): 4HBD (Lipinski): ┄#RO5 Violations (Lipinski): 2CX Acidic pKa: ┄CX Basic pKa: 1.31CX LogP: 9.40CX LogD: 9.40Aromatic Rings: 6Heavy Atoms: 38QED Weighted: 0.22Np Likeness Score: -0.73
References 1. Sarkate AP, Dofe VS, Tiwari SV, Lokwani DK, Karnik KS, Kamble DD, Ansari MHSH, Dodamani S, Jalalpure SS, Sangshetti JN, Azad R, Burra PVLS, Bhandari SV.. (2021) One pot synthesis, in silico study and evaluation of some novel flavonoids as potent topoisomerase II inhibitors., 40 [PMID:33689875 ] [10.1016/j.bmcl.2021.127916 ]